Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management
|
December 14, 2017
New Heart Failure Medications Aim To Fill Significant Gaps in Treatment
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
August 14, 2018
Old and New Drug Classes Expanding To Include Glaucoma Treatments
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
April 7, 2018
Intense Focus Yet Many Setbacks for Alzheimer's Disease Drug Development
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 14, 2018
Targeting Remission in Moderate-to-Severe Crohn's Disease
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
February 2, 2018
New Antibiotics in Development Target Highly Resistant Gram-Negative Organisms
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
December 19, 2018
Promising Multiple Sclerosis Agents In Late-Stage Development
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
October 2, 2018
Emerging Therapies for Patients With Difficult-to-Treat Migraine
Troy Kish
American Journal of Therapeutics
|
January 13, 2015
Sertraline-Induced Rhabdomyolysis: A Case Report and Literature Review
Mitchell Snyder, Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 11, 2016
Sonidegib (Odomzo) for the Systemic Treatment of Adults With Recurrent, Locally Advanced Basal Cell Skin Cancer
Troy Kish, Lauren Corry
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 11, 2016
Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer
Troy Kish, Priyasha Uppal
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
P & T : a Peer-Reviewed Journal for Formulary Management
|
December 14, 2017
New Heart Failure Medications Aim To Fill Significant Gaps in Treatment
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
August 14, 2018
Old and New Drug Classes Expanding To Include Glaucoma Treatments
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
April 7, 2018
Intense Focus Yet Many Setbacks for Alzheimer's Disease Drug Development
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 14, 2018
Targeting Remission in Moderate-to-Severe Crohn's Disease
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
February 2, 2018
New Antibiotics in Development Target Highly Resistant Gram-Negative Organisms
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
December 19, 2018
Promising Multiple Sclerosis Agents In Late-Stage Development
Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
October 2, 2018
Emerging Therapies for Patients With Difficult-to-Treat Migraine
Troy Kish
American Journal of Therapeutics
|
January 13, 2015
Sertraline-Induced Rhabdomyolysis: A Case Report and Literature Review
Mitchell Snyder, Troy Kish
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 11, 2016
Sonidegib (Odomzo) for the Systemic Treatment of Adults With Recurrent, Locally Advanced Basal Cell Skin Cancer
Troy Kish, Lauren Corry
P & T : a Peer-Reviewed Journal for Formulary Management
|
May 11, 2016
Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer
Troy Kish, Priyasha Uppal
Page
of 2